Using screening tools to identify neuropathic pain.

Pain

Senior Clinical Lecturer in Palliative Medicine, Clinical Teaching and Research Unit, St. Gemma's Hospice, 329 Harrogate Road, Leeds LS17 6QD, UK Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Pare, Paris, France Department of Neurology, University of Wisconsin Medical School, Wisconsin, USA Department of Neurological Pain Research and Therapy, Universitätsklinikum Schleswig-Holstein, Kiel, Germany Pain Clinic, Kinik für Anaesthesiologie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany Neural Plasticity Research Group, Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA Neurology Clinic, Technische Universität München, Munich, Germany Department of Psychology, Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany Danish Pain Research Center, Åarhus University Hospital, Åarhus, Denmark.

Published: February 2007

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pain.2006.10.034DOI Listing

Publication Analysis

Top Keywords

screening tools
4
tools identify
4
identify neuropathic
4
neuropathic pain
4
screening
1
identify
1
neuropathic
1
pain
1

Similar Publications

Background: Breast cancer remains a significant global health challenge, requiring innovative therapeutic strategies. In silico methods, which leverage computational tools, offer a promising pathway for vaccine development. These methods facilitate antigen identification, epitope prediction, immune response modelling, and vaccine optimization, accelerating the design process.

View Article and Find Full Text PDF

Purpose Of Review: Trigeminal neuralgia (TN) is a highly heterogeneous condition with a wide choice of successful treatment options. However, differences between subtypes are poorly understood and it remains unknown which patients will respond to different treatments. This review aims to summarize the current state of the TN field and explore the problem of predicting surgical outcomes.

View Article and Find Full Text PDF

A key component of ecological risk assessments is to develop evidence-based benchmarks to assess potential hazards to various receptors. To ensure that toxicity value development is performed using the best available science, the reliability (or inherent scientific quality) of these studies must be considered. The degree of reliability can be evaluated via critical appraisal tools (CATs), though application of such methods assessing ecotoxicological literature for toxicity value development is not well established compared to human health assessments.

View Article and Find Full Text PDF

Screening for comprehensive social needs in patients with cancer: a narrative review.

JNCI Cancer Spectr

January 2025

Department of Hematology/Oncology, Kaiser Permanente, San Francisco Medical Center, San Francisco, CA, United States.

Background: Patients with cancer who report social needs have worse quality of life, lower healthcare access, and suboptimal health outcomes. However, screening for social needs does not happen systematically and successful screening tools, strategies, and workflows have seldom been described. The downstream effects of screening including resource navigation have also not been well characterized.

View Article and Find Full Text PDF

Objective: Social-ecological factors are highly congruent with social determinants of health (SDOH): Economic Stability; Educational Access/Quality; Healthcare Access/Quality; Neighborhood/Built Environment; and Social/Community Context. In this topical review, the correspondence of social-ecological theory with SDOH and assessment approaches is reviewed. The Psychosocial Assessment Tool (PAT) is used to show how existing tools may facilitate SDOH screening.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!